Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...

Being the only product on the market, GSK’s vaccine has ... as HPV-induced cervical cancer vaccine Cervarix (human papillomavirus bivalent vaccine) and malaria jab Mosquirix (RTS,S/AS01 ...

Final results from a landmark study looking at the use of GSK's Mosquirix malaria vaccine alongside antimalarial drugs and other measures have shown a 90%-plus reduction in cases. The study in ...

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

GlaxoSmithKline’s experimental malaria vaccine, RTS,S, has proved only 30% effective when administered to babies, as part of Africa’s largest ever clinical trial. There is a lot of pressure on ...

The Trump administration intends to terminate the United States’ financial support for Gavi, the organization that has helped purchase critical ...

Expert Rev Vaccines. 2008;7(2):223-240. The EMVI is currently supporting preclinical activities at the Statens Serum Institute in Copenhagen and the Institut Pasteur in Paris for the development ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...